ID   MDFSP-S1
AC   CVCL_D4A8
DR   Wikidata; Q127382793
RX   PubMed=37610680;
CC   Population: Chinese.
CC   Characteristics: Imatinib resistant (PubMed=37610680).
CC   Doubling time: ~5 days (PubMed=37610680).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=37610680).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=37610680).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2197; COL1A1 + HGNC; HGNC:8800; PDGFB; Name(s)=COL1A1-PDGFB (PubMed=37610680).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Right gluteal muscle; UBERON=UBERON_0002000.
ST   Source(s): PubMed=37610680
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 17,18
ST   D13S317: 10,13
ST   D16S539: 10,12
ST   D18S51: 13,17
ST   D19S433: 14,15.2
ST   D1S1656: 13,14
ST   D21S11: 27,32
ST   D22S1045: 15
ST   D2S1338: 19,24
ST   D2S441: 10,14
ST   D3S1358: 15,16
ST   D5S818: 7,10
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   Penta D: 8,10
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
RX   PubMed=37610680; DOI=10.1007/s13577-023-00974-8;
RA   Chan J.Y.-S., Lee E.C.-Y., Li Z.-M., Lee J.-Y., Lim A.H., Poon E.;
RT   "Multi-omic profiling and real time ex vivo modelling of
RT   imatinib-resistant dermatofibrosarcoma protuberans with
RT   fibrosarcomatous transformation.";
RL   Hum. Cell 36:2228-2236(2023).
//